中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2013年
22期
9857-9860
,共4页
丁文才%李付勇%任占秀%张贺敏%邹建军%何秋
丁文纔%李付勇%任佔秀%張賀敏%鄒建軍%何鞦
정문재%리부용%임점수%장하민%추건군%하추
偏头痛%过氧化物酶体增殖物激活受体%炎症%发病机制
偏頭痛%過氧化物酶體增殖物激活受體%炎癥%髮病機製
편두통%과양화물매체증식물격활수체%염증%발병궤제
Migraine disorders%Peroxisome proliferator-activated receptors%Inflammation%Pathogenesis
目的:观察不同时期及不同亚型偏头痛患者血清中过氧化物酶体增殖物激活受体γ(peroxisome proliferator-activated receptorγ,PPARγ)水平变化,探讨其与偏头痛的关系及临床意义。方法收集偏头痛患者105例,随机分成偏头痛发作期组(A 组,n=47)和偏头痛发作间期组(B 组,n=58),再根据患者有无先兆症状进一步分成四个亚组,同时选取100例健康者作为对照组。采用酶联免疫法(ELISA)检测受试者血清PPARγ水平,采用SPSS系统软件进行统计分析。结果偏头痛患者发作期PPARγ水平明显低于发作间期及健康对照者(P<0.01);发作间期的 PPARγ水平与健康对照者相比无明显统计学差异(P>0.05);有先兆与无先兆发作期PPARγ水平比较无明显差异(P>0.05);有先兆和无先兆发作间期PPARγ水平无明显统计学差异(P>0.05)。结论偏头痛发作时血清PPARγ下调,其可能是偏头痛发病的潜在机制之一。有无先兆对PPARγ水平无明显影响。
目的:觀察不同時期及不同亞型偏頭痛患者血清中過氧化物酶體增殖物激活受體γ(peroxisome proliferator-activated receptorγ,PPARγ)水平變化,探討其與偏頭痛的關繫及臨床意義。方法收集偏頭痛患者105例,隨機分成偏頭痛髮作期組(A 組,n=47)和偏頭痛髮作間期組(B 組,n=58),再根據患者有無先兆癥狀進一步分成四箇亞組,同時選取100例健康者作為對照組。採用酶聯免疫法(ELISA)檢測受試者血清PPARγ水平,採用SPSS繫統軟件進行統計分析。結果偏頭痛患者髮作期PPARγ水平明顯低于髮作間期及健康對照者(P<0.01);髮作間期的 PPARγ水平與健康對照者相比無明顯統計學差異(P>0.05);有先兆與無先兆髮作期PPARγ水平比較無明顯差異(P>0.05);有先兆和無先兆髮作間期PPARγ水平無明顯統計學差異(P>0.05)。結論偏頭痛髮作時血清PPARγ下調,其可能是偏頭痛髮病的潛在機製之一。有無先兆對PPARγ水平無明顯影響。
목적:관찰불동시기급불동아형편두통환자혈청중과양화물매체증식물격활수체γ(peroxisome proliferator-activated receptorγ,PPARγ)수평변화,탐토기여편두통적관계급림상의의。방법수집편두통환자105례,수궤분성편두통발작기조(A 조,n=47)화편두통발작간기조(B 조,n=58),재근거환자유무선조증상진일보분성사개아조,동시선취100례건강자작위대조조。채용매련면역법(ELISA)검측수시자혈청PPARγ수평,채용SPSS계통연건진행통계분석。결과편두통환자발작기PPARγ수평명현저우발작간기급건강대조자(P<0.01);발작간기적 PPARγ수평여건강대조자상비무명현통계학차이(P>0.05);유선조여무선조발작기PPARγ수평비교무명현차이(P>0.05);유선조화무선조발작간기PPARγ수평무명현통계학차이(P>0.05)。결론편두통발작시혈청PPARγ하조,기가능시편두통발병적잠재궤제지일。유무선조대PPARγ수평무명현영향。
Objective To investigate the PPARγlevel in serum and its relationship with migraine and clinical implications. Methods Hundred and five patients with migraine were divided into two main groups:attack period group (n=47) and attack free period group (n=58). According to the patients with or without aura symptoms patients were further divided into four subgroups. One hundred cases of healthy were taken as control. The serum levels of PPARγ were measured using enzyme-linked immunoassay (ELISA). Results The PPARγlevels in patients with migraine during headache attack period were significantly lower than those during headache free period and healthy control group (P<0.01). The PPARγ levels in headache free period had no significant difference to healthy control group (P>0.05). Conclusions Migraine inflammatory cells immune activation may be associated with lower PPARγ, and participate in the onset of migraine. The PPARγlevel reduction is one of the underlying mechanisms of migraine pathogenesis.